Top Losers: AVEO Pharmaceuticals (NASDAQ:AVEO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Oncothyreon Inc (NASDAQ:ONTY), Omeros Corporation (NASDAQ:OMER)

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported a fourth-quarter 2013 loss of 32 cents per share (excluding one-time expenses), narrower than the year-ago loss of 43 cents per share and the Zacks Consensus Estimate of a loss of 40 cents. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock performance was -6.08% in last session and finished the day at $1.70. Traded volume was 1.35million shares in the last session and … Continue reading Top Losers: AVEO Pharmaceuticals (NASDAQ:AVEO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Oncothyreon Inc (NASDAQ:ONTY), Omeros Corporation (NASDAQ:OMER)

Biotech Overbought Socks: Xencor Inc. (NASDAQ:XNCR), Albany Molecular Research (NASDAQ:AMRI), Oncothyreon (NASDAQ:ONTY), OXiGENE Inc. (NASDAQ:OXGN)

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor Inc. (NASDAQ:XNCR) stock performance was -1.58% in last session and finished the day at $13.68. Traded volume was 99,904.00 shares … Continue reading Biotech Overbought Socks: Xencor Inc. (NASDAQ:XNCR), Albany Molecular Research (NASDAQ:AMRI), Oncothyreon (NASDAQ:ONTY), OXiGENE Inc. (NASDAQ:OXGN)

FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Oncothyreon (NASDAQ:ONTY), IGI Laboratories (NYSEMKT:IG), TG Therapeutics (NASDAQ:TGTX), Receptos Inc. (NASDAQ:RCPT)

4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its full year and fourth quarter 2013 financial results and provide a review of its pipeline of products in development. Oncothyreon Inc. (USA) (NASDAQ:ONTY) stock performance was 1.92% in last session and finished the day at $3.72. Traded volume was 1.16 million shares in the last session and the average volume of the stock remained 904,463.00 … Continue reading Biotech Stocks Touching New Highs: Oncothyreon (NASDAQ:ONTY), IGI Laboratories (NYSEMKT:IG), TG Therapeutics (NASDAQ:TGTX), Receptos Inc. (NASDAQ:RCPT)

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day at $26.31. Traded volume was 7,684,553 million shares in the … Continue reading Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Market Watch: Gerdau S.A. (NYSE:GGB), Oncothyreon Inc (NASDAQ:ONTY), Zebra Technologies Corp. (NASDAQ:ZBRA), SM Energy Company (NYSE:SM), CAMAC Energy, Inc. (NYSEMKT:CAK)

Standard & Poor’s Ratings Services affirmed its ‘BBB-‘ global scale and ‘brAAA’ Brazil national scale ratings on Gerdau S.A. (NYSE:GGB). We are also affirming our ‘BBB-‘ rating on Gerdau Ameristeel Corp., Gerdau’s North American subsidiary. The outlooks on all the ratings are stable. Gerdau S.A. (NYSE:GGB) belongs to Basic Materials sector. Its net profit margin is 3.50% and weekly performance is -20.36%. On last trading … Continue reading Market Watch: Gerdau S.A. (NYSE:GGB), Oncothyreon Inc (NASDAQ:ONTY), Zebra Technologies Corp. (NASDAQ:ZBRA), SM Energy Company (NYSE:SM), CAMAC Energy, Inc. (NYSEMKT:CAK)

Trader’s Recap: Hertz Global Holdings, Inc. (NYSE:HTZ), TheStreet, Inc. (NASDAQ:TST), Douglas Dynamics, Inc. (NYSE:PLOW), Balchem Corp. (NASDAQ:BCPC), Oncothyreon Inc (NASDAQ:ONTY)

Hertz Global Holdings (NYSE:HTZ) CEO John P. Tague bought 84,200 shares of the stock on the open market in a transaction that occurred on Monday, November 24th. The stock was purchased at an average cost of $24.11 per share, with a total value of $2,030,062.00. Hertz Global Holdings, Inc. (NYSE:HTZ) belongs to Services sector. Its net profit margin is 6.50% and weekly performance is -0.08%. … Continue reading Trader’s Recap: Hertz Global Holdings, Inc. (NYSE:HTZ), TheStreet, Inc. (NASDAQ:TST), Douglas Dynamics, Inc. (NYSE:PLOW), Balchem Corp. (NASDAQ:BCPC), Oncothyreon Inc (NASDAQ:ONTY)